DZ Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.16B | Buy |
1,263,243
+279,019
| +28% | +$283M | 1.03% | 25 |
|
|
2025
Q4 | $1.06B | Sell |
984,224
-67,769
| -6% | -$64.8M | 0.91% | 26 |
|
|
2025
Q3 | $802M | Sell |
1,051,993
-113,280
| -10% | -$84.3M | 0.7% | 38 |
|
|
2025
Q2 | $908M | Sell |
1,165,273
-948,563
| -45% | -$737M | 0.91% | 26 |
|
|
2025
Q1 | $1.75B | Buy |
2,113,836
+273,324
| +15% | +$227M | 1.95% | 8 |
|
|
2024
Q4 | $1.42B | Sell |
1,840,512
-435,694
| -19% | -$361M | 1.44% | 17 |
|
|
2024
Q3 | $2.02B | Buy |
2,276,206
+306,091
| +16% | +$275M | 1.98% | 7 |
|
|
2024
Q2 | $1.78B | Sell |
1,970,115
-1,118,724
| -36% | -$895M | 1.83% | 10 |
|
|
2024
Q1 | $2.4B | Buy |
3,088,839
+315,434
| +11% | +$224M | 2.58% | 7 |
|
|
2023
Q4 | $1.62B | Sell |
2,773,405
-657,527
| -19% | -$384M | 2.01% | 9 |
|
|
2023
Q3 | $1.84B | Buy |
3,430,932
+429,783
| +14% | +$221M | 2.62% | 7 |
|
|
2023
Q2 | $1.41B | Buy |
3,001,149
+300,084
| +11% | +$126M | 2.12% | 9 |
|
|
2023
Q1 | $928M | Sell |
2,701,065
-64,173
| -2% | -$21.6M | 1.53% | 13 |
|
|
2022
Q4 | $1.01B | Buy |
2,765,238
+227,474
| +9% | +$80.7M | 1.76% | 12 |
|
|
2022
Q3 | $821M | Buy |
2,537,764
+255,904
| +11% | +$81.1M | 1.55% | 18 |
|
|
2022
Q2 | $740M | Sell |
2,281,860
-1,473,646
| -39% | -$442M | 1.33% | 20 |
|
|
2022
Q1 | $1.08B | Sell |
3,755,506
-769,622
| -17% | -$198M | 1.61% | 9 |
|
|
2021
Q4 | $1.25B | Buy |
4,525,128
+1,257,817
| +38% | +$319M | 1.78% | 9 |
|
|
2021
Q3 | $755M | Buy |
3,267,311
+1,214,841
| +59% | +$300M | 1.2% | 23 |
|
|
2021
Q2 | $471M | Buy |
2,052,470
+1,566,525
| +322% | +$315M | 0.77% | 40 |
|
|
2021
Q1 | $90.8M | Sell |
485,945
-2,092,957
| -81% | -$409M | 0.17% | 100 |
|
|
2020
Q4 | $431M | Buy |
2,578,902
+1,866,979
| +262% | +$279M | 0.91% | 28 |
|
|
2020
Q3 | $105M | Buy |
711,923
+181,284
| +34% | +$28.1M | 0.25% | 84 |
|
|
2020
Q2 | $87.1M | Buy |
530,639
+62,494
| +13% | +$9.59M | 0.24% | 86 |
|
|
2020
Q1 | $64.9M | Buy |
468,145
+55,495
| +13% | +$7.62M | 0.22% | 94 |
|
|
2019
Q4 | $54.2M | Sell |
412,650
-2,457
| -0.6% | -$285K | 0.14% | 110 |
|
|
2019
Q3 | $46.4M | Sell |
415,107
-1,491,432
| -78% | -$166M | 0.14% | 117 |
|
|
2019
Q2 | $211M | Sell |
1,906,539
-486,598
| -20% | -$57.3M | 0.65% | 45 |
|
|
2019
Q1 | $311M | Buy |
2,393,137
+645,514
| +37% | +$78.5M | 1.01% | 26 |
|
|
2018
Q4 | $200M | Buy |
1,747,623
+592,435
| +51% | +$66.2M | 0.77% | 37 |
|
|
2018
Q3 | $124M | Buy |
1,155,188
+443,328
| +62% | +$44.3M | 0.44% | 73 |
|
|
2018
Q2 | $60.7M | Sell |
711,860
-93,934
| -12% | -$7.72M | 0.22% | 111 |
|
|
2018
Q1 | $62.3M | Buy |
805,794
+84,907
| +12% | +$6.84M | 0.24% | 109 |
|
|
2017
Q4 | $60.9M | Buy |
720,887
+25,787
| +4% | +$2.19M | 0.23% | 108 |
|
|
2017
Q3 | $59.5M | Buy |
695,100
+26,984
| +4% | +$2.21M | 0.25% | 106 |
|
|
2017
Q2 | $55M | Buy |
668,116
+21,648
| +3% | +$1.77M | 0.25% | 104 |
|
|
2017
Q1 | $54.4M | Buy |
646,468
+14,160
| +2% | +$1.13M | 0.25% | 110 |
|
|
2016
Q4 | $46.5M | Buy |
+632,308
| New | +$47.1M | 0.22% | 125 |
|
Other funds holding LLY
VCM
VPM
DZ Bank's LLY Position: Q1 2026 in Review
DZ Bank increased its Eli Lilly (LLY) stake by 28% in Q1 2026, buying an estimated $283M and bringing the position to 1,263,243 shares worth $1.16B. The position accounts for 1.03% of the portfolio, ranked #25.
DZ Bank first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.4B in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- DZ Bank held 1,263,243 shares of Eli Lilly worth $1.16B as of Q1 2026.
- DZ Bank bought 279,019 Eli Lilly shares in Q1 2026, an estimated $283M.
- Eli Lilly made up 1.03% of DZ Bank's portfolio in Q1 2026, its #25 holding.
- DZ Bank first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
- DZ Bank's Eli Lilly position peaked at $2.4B in Q1 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.